Matches in Wikidata for { <http://www.wikidata.org/entity/Q91065064> ?p ?o ?g. }
Showing items 1 to 49 of
49
with 100 items per page.
- Q91065064 description "artículu científicu espublizáu en payares de 2019" @default.
- Q91065064 description "scientific article published on 02 November 2019" @default.
- Q91065064 description "wetenschappelijk artikel" @default.
- Q91065064 description "наукова стаття, опублікована 2 листопада 2019" @default.
- Q91065064 name "Real-world survival of patients with advanced BRAF V600 mutated melanoma treated with front-line BRAF/MEK inhibitors, anti-PD-1 antibodies, or nivolumab/ipilimumab" @default.
- Q91065064 name "Real-world survival of patients with advanced BRAF V600 mutated melanoma treated with front-line BRAF/MEK inhibitors, anti-PD-1 antibodies, or nivolumab/ipilimumab" @default.
- Q91065064 type Item @default.
- Q91065064 label "Real-world survival of patients with advanced BRAF V600 mutated melanoma treated with front-line BRAF/MEK inhibitors, anti-PD-1 antibodies, or nivolumab/ipilimumab" @default.
- Q91065064 label "Real-world survival of patients with advanced BRAF V600 mutated melanoma treated with front-line BRAF/MEK inhibitors, anti-PD-1 antibodies, or nivolumab/ipilimumab" @default.
- Q91065064 prefLabel "Real-world survival of patients with advanced BRAF V600 mutated melanoma treated with front-line BRAF/MEK inhibitors, anti-PD-1 antibodies, or nivolumab/ipilimumab" @default.
- Q91065064 prefLabel "Real-world survival of patients with advanced BRAF V600 mutated melanoma treated with front-line BRAF/MEK inhibitors, anti-PD-1 antibodies, or nivolumab/ipilimumab" @default.
- Q91065064 P1433 Q91065064-C5FA58E1-A74A-4C3E-A166-B8B2155A4E94 @default.
- Q91065064 P1476 Q91065064-0E17FEDD-0C24-4996-96C5-1E6E39F829ED @default.
- Q91065064 P2093 Q91065064-BF991F38-6D4B-416F-834A-E8236B51F217 @default.
- Q91065064 P2093 Q91065064-CD036FDE-5701-4400-813D-3AF0CEDD4E9A @default.
- Q91065064 P2093 Q91065064-D7586D1D-700B-42F0-823C-F34D031705B6 @default.
- Q91065064 P2093 Q91065064-DD26DA9E-98A3-4C5B-8790-624CF3A4FF3B @default.
- Q91065064 P2093 Q91065064-DE38AAD4-D7D1-4286-A1FF-3A800D68C272 @default.
- Q91065064 P2093 Q91065064-FFA175FA-CAF1-4D50-8F76-FDFEFD043153 @default.
- Q91065064 P304 Q91065064-0C5D32D2-0C8D-44BF-B47F-285E5FA3AA3D @default.
- Q91065064 P31 Q91065064-853C68D2-A3C8-46CE-B486-B148AE098CA0 @default.
- Q91065064 P356 Q91065064-3431D1FE-8DA5-4697-BA00-6AFD715B9E59 @default.
- Q91065064 P433 Q91065064-9C54FF15-FBE6-4BC3-8AC9-CFE6E42E4562 @default.
- Q91065064 P478 Q91065064-E422D6A1-B39A-4865-83ED-F529F039271C @default.
- Q91065064 P50 Q91065064-1D03BD4E-33B8-491B-8A9F-6BE2397F7781 @default.
- Q91065064 P50 Q91065064-85926532-9183-4DB1-B471-28B7F13D6135 @default.
- Q91065064 P577 Q91065064-2AEE8036-A786-4F4B-8ABD-9365953DDD6C @default.
- Q91065064 P698 Q91065064-05F77545-881A-4C0C-9920-E83B1CFFB9B7 @default.
- Q91065064 P932 Q91065064-65904089-C412-45AF-80C1-3B813091EC06 @default.
- Q91065064 P356 CAM4.2625 @default.
- Q91065064 P698 31677253 @default.
- Q91065064 P1433 Q27724564 @default.
- Q91065064 P1476 "Real-world survival of patients with advanced BRAF V600 mutated melanoma treated with front-line BRAF/MEK inhibitors, anti-PD-1 antibodies, or nivolumab/ipilimumab" @default.
- Q91065064 P2093 "Danli Chen" @default.
- Q91065064 P2093 "Jian Ying" @default.
- Q91065064 P2093 "John R Hyngstrom" @default.
- Q91065064 P2093 "Kenneth F Grossmann" @default.
- Q91065064 P2093 "Sarah V Colonna" @default.
- Q91065064 P2093 "Shiven Patel" @default.
- Q91065064 P304 "7637-7643" @default.
- Q91065064 P31 Q13442814 @default.
- Q91065064 P356 "10.1002/CAM4.2625" @default.
- Q91065064 P433 "18" @default.
- Q91065064 P478 "8" @default.
- Q91065064 P50 Q115922425 @default.
- Q91065064 P50 Q91065061 @default.
- Q91065064 P577 "2019-11-02T00:00:00Z" @default.
- Q91065064 P698 "31677253" @default.
- Q91065064 P932 "6912019" @default.